SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Saxagliptin And Metformin Hydrochloride, and what generic alternatives are available?
Saxagliptin And Metformin Hydrochloride is a drug marketed by Mylan and Sun Pharm and is included in two NDAs.
The generic ingredient in SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE is metformin hydrochloride; saxagliptin hydrochloride. There are forty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; saxagliptin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Saxagliptin And Metformin Hydrochloride
A generic version of SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE was approved as metformin hydrochloride; saxagliptin hydrochloride by DR REDDYS LABS SA on August 9th, 2023.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE?
- What are the global sales for SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE?
- What is Average Wholesale Price for SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE?
Summary for SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 60 |
| DailyMed Link: | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sabyasachi Sen | Phase 4 |
| the Fifth Affiliated Hospital of Zunyi Medical University | Phase 4 |
| Peking University Shenzhen Hospital | Phase 4 |
See all SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE clinical trials
Pharmacology for SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
| Drug Class | Biguanide Dipeptidyl Peptidase 4 Inhibitor |
| Mechanism of Action | Dipeptidyl Peptidase 4 Inhibitors |
US Patents and Regulatory Information for SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | metformin hydrochloride; saxagliptin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205981-002 | Jul 31, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | metformin hydrochloride; saxagliptin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 206081-002 | Jul 31, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | metformin hydrochloride; saxagliptin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205981-003 | Jul 31, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
